42 / 64
40
POSTERS
| PROGRAMME & EXHIBITION GUIDE
Hypofractionated radiotherapy for head and neck cancer patients unfit for
standard treatment
I. Desideri (Italy), P. Bonomo, C. Ciabatti, C. Muntoni, M. Lo Russo, M. Loi,
D. Greto, I. Meattini, L. Livi
PO-148
Survival outcomes for very elderly patients after definitive radiotherapy for
head and neck cancer
L.M. Dixon (UK), K. Garcez, L.W. Lee, A.J. Sykes, N.J. Slevin, D.J. Thomson
PO-149
Age ≥70 is not an adverse prognostic factor for accelerated radiotherapy in
head and neck cancer
C. Terhaard (The Netherlands), N. Kasperts, H. Dehnad, E. Smid,
L. Janssen, R.G. Wiggenraad, C.P.J. Raaijmakers
PO-150
Poster
Immunodiagnosis and immunotherapy
Immunotherapy for refractory brain metastasis in cases of oropharangeal
squamous cell carcinoma
M. Bhandari (USA), P. Vora, A. Dugar, S. Bhati, A. DeFranco, E. Guenther
PO-151